Form 8-K - Current report:
SEC Accession No. 0001104659-25-039470
Filing Date
2025-04-25
Accepted
2025-04-25 16:30:19
Documents
13
Period of Report
2025-04-24
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2513203d1_8k.htm   iXBRL 8-K 43804
  Complete submission text file 0001104659-25-039470.txt   219492

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vrna-20250424.xsd EX-101.SCH 3026
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrna-20250424_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrna-20250424_pre.xml EX-101.PRE 22366
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2513203d1_8k_htm.xml XML 3657
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Filer) CIK: 0001657312 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38067 | Film No.: 25874587
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)